# AHG (Akso Health Group) - SEC EDGAR Financial Statements

> Akso Health Group reported $13.83M in revenue and a net loss of $18.67M for the fiscal year ended March 31, 2026 (down 6.4% year over year), with a -0.1% gross margin and a -149.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/AHG
- Markdown: https://convexityos.com/fundamentals/AHG.md
- SEC CIK: 0001702318
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:30 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001702318&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $13.83M | -6.4% YoY |
| Operating Income | FY 2026 | -$20.70M | -149.7% margin |
| Net Income | FY 2026 | -$18.67M | -135.0% net margin |
| Diluted EPS | FY 2026 | $0.01 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$12.79M | -92.5% FCF margin |
| Cash & ST Investments | Mar 31, 2026 | $171K | Total debt: $25K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $13.83M | $14.78M | $2.41M | $13.18M | $6.00M | $1.75M | $6.91M | $3.70M | $107.3M | $22.92M |
| Cost of Revenue | $13.84M | $15.06M | $2.29M | $11.91M | $5.39M | $545K | $1.03M | $7.40M | $8.50M | $5.15M |
| **Gross Profit** | -$11K | -$282K | $122K | $1.27M | $605K | $1.75M | $6.91M | -$3.70M | $107.3M | $22.92M |
| Research & Development | -- | -- | -- | -- | $421K | $441K | $118K | $0 | $2.82M | $1.57M |
| Selling, General & Admin | $3.99M | $3.64M | $8.59M | $15.54M | $2.91M | $3.12M | $21.95M | $4.30M | $21.06M | $7.86M |
| Total Operating Expenses | $20.69M | $166.0M | $8.76M | $15.54M | $3.87M | $4.24M | $55.02M | -- | $31.38M | $13.01M |
| **Operating Income** | -$20.70M | -$166.3M | -$8.64M | -$14.27M | -$3.26M | -$4.24M | -$48.11M | -$7.19M | $75.88M | $9.91M |
| **EBITDA** | -$18.33M | -$164.2M | -- | -- | -$3.24M | -$4.23M | -$47.99M | -$7.17M | $76.05M | $10.01M |
| Interest Expense | -- | -- | -- | -- | $804K | $2.15M | -- | -- | -- | -- |
| Income Before Tax | -$20.70M | -$166.3M | -$9.09M | -$13.07M | -$4.01M | -$4.29M | -$46.87M | -$6.81M | $76.54M | $10.09M |
| Income Tax Expense | -$1.99M | -$30.80M | $25K | $18K | $93K | $483K | $490K | $808K | $11.03M | $1.52M |
| **Net Income** | -$18.67M | -$135.0M | -$9.46M | -$1.36M | -$16.85M | -$34.83M | -$71.20M | $5.53M | $65.48M | $8.57M |
| Basic EPS | $0.01 | $0.16 | $0.07 | -$0.02 | -$0.28 | -$0.71 | -$1.46 | $0.11 | $1.46 | $0.20 |
| **Diluted EPS** | $0.01 | $0.16 | $0.07 | -$0.02 | -$0.28 | -$0.71 | -$1.46 | $0.10 | $1.37 | $0.20 |
| Basic Shares Outstanding | 2.17B | 855.3M | 141.5M | 68.6M | 59.6M | 48.8M | 48.8M | 48.7M | 45.0M | 42.3M |
| Diluted Shares Outstanding | 2.17B | 855.3M | 141.5M | 68.6M | 59.6M | 48.8M | 48.8M | 52.9M | 47.7M | 42.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $171K | $176.2M | $85.17M | $7.92M | $18.43M | $15.13M | $6.67M | $57.37M | $132.6M | $19.23M |
| **Cash & Short-Term Investments** | $171K | $176.2M | $85.17M | $7.92M | $18.43M | $15.13M | $6.67M | $57.37M | $132.6M | $19.23M |
| Accounts Receivable, Net | $1.28M | $954K | -- | $7.70M | -- | -- | -- | $141K | $0 | -- |
| Inventory | $200K | $190K | $191K | $1.69M | $7.80M | -- | -- | -- | -- | -- |
| **Total Current Assets** | $189.5M | $196.1M | $142.0M | $20.46M | $62.81M | $30.12M | $52.02M | $97.68M | $163.1M | -- |
| Property, Plant & Equipment, Net | $12K | $16K | -- | -- | $55K | $67K | $93K | $1.25M | $767K | $428K |
| Goodwill | -- | $10.83M | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $58K | $7.88M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $87K | $18.83M | $0 | $0 | $0 | $1.56M | $28.46M | $75.58M | $767K | -- |
| **Total Assets** | $189.6M | $215.0M | $142.0M | $20.46M | $62.81M | $31.69M | $80.48M | $173.3M | $163.9M | $28.38M |
| Deferred Revenue (Current) | $4.41M | $10.22M | $415K | $194K | -- | -- | $125K | $111K | -- | -- |
| Other Current Liabilities | $2.00M | $2.00M | $2.00M | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $8.71M | $13.81M | $3.59M | $11.62M | $50.52M | $14.41M | $12.36M | $26.56M | $23.85M | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $96K | $190K | -- | -- |
| **Total Non-Current Liabilities** | $2.6K | $1.99M | $0 | $0 | $0 | $0 | $20.01M | $20.19M | $0 | -- |
| **Total Liabilities** | $8.71M | $15.80M | $3.59M | $11.62M | $50.52M | $14.41M | $32.38M | $46.75M | $23.85M | $4.88M |
| **Total Debt (incl. Leases)** | $25K | $82K | -- | -- | -- | -- | $792K | -- | -- | -- |
| Common Stock | -- | $166K | $44K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $4.8K | $4.3K |
| Retained Earnings | -$217.6M | -$198.9M | -$63.93M | -$54.47M | -$53.11M | -$36.26M | -$1.43M | $69.77M | $77.24M | $11.76M |
| Accumulated Other Comp. Income | -$3.28M | -$3.77M | -$4.09M | -$3.85M | -$1.65M | -$3.10M | -$7.05M | -$1.76M | $4.38M | -$1.54M |
| **Total Stockholders' Equity** | $180.9M | $199.1M | $138.4M | $8.73M | $12.28M | $17.27M | $48.10M | $126.5M | $140.0M | $23.50M |
| Total Equity | $180.9M | $199.2M | $138.4M | $8.84M | $12.29M | $17.27M | $48.10M | $126.5M | $140.2M | $23.50M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $171K | $176.2M | $85.17M | $7.92M | $18.43M | $15.13M | $6.67M | $57.37M |
| **Cash & Short-Term Investments** | $171K | $176.2M | $85.17M | $7.92M | $18.43M | $15.13M | $6.67M | $57.37M |
| Accounts Receivable, Net | $1.28M | $954K | -- | $7.70M | -- | -- | -- | $141K |
| Inventory | $200K | $190K | $191K | $1.69M | $7.80M | -- | -- | -- |
| **Total Current Assets** | $189.5M | $196.1M | $142.0M | $20.46M | $62.81M | $30.12M | $52.02M | $97.68M |
| Property, Plant & Equipment, Net | $12K | $16K | -- | -- | $55K | $67K | $93K | $1.25M |
| Goodwill | -- | $10.83M | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $58K | $7.88M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $87K | $18.83M | $0 | $0 | $0 | $1.56M | $28.46M | $75.58M |
| **Total Assets** | $189.6M | $215.0M | $142.0M | $20.46M | $62.81M | $31.69M | $80.48M | $173.3M |
| Deferred Revenue (Current) | $4.41M | $10.22M | $415K | $194K | -- | -- | $125K | $111K |
| Other Current Liabilities | $2.00M | $2.00M | $2.00M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $8.71M | $13.81M | $3.59M | $11.62M | $50.52M | $14.41M | $12.36M | $26.56M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $96K | $190K |
| **Total Non-Current Liabilities** | $2.6K | $1.99M | $0 | $0 | $0 | $0 | $20.01M | $20.19M |
| **Total Liabilities** | $8.71M | $15.80M | $3.59M | $11.62M | $50.52M | $14.41M | $32.38M | $46.75M |
| **Total Debt (incl. Leases)** | $25K | $82K | -- | -- | -- | -- | $792K | -- |
| Common Stock | -- | $166K | $44K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$217.6M | -$198.9M | -$63.93M | -$54.47M | -$53.11M | -$36.26M | -$1.43M | $69.77M |
| Accumulated Other Comp. Income | -$3.28M | -$3.77M | -$4.09M | -$3.85M | -$1.65M | -$3.10M | -$7.05M | -$1.76M |
| **Total Stockholders' Equity** | $180.9M | $199.1M | $138.4M | $8.73M | $12.28M | $17.27M | $48.10M | $126.5M |
| Total Equity | $180.9M | $199.2M | $138.4M | $8.84M | $12.29M | $17.27M | $48.10M | $126.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18.72M | -$135.5M | -$9.52M | -$1.25M | -$16.85M | -$34.83M | -$71.20M | $5.53M | $65.51M | $8.57M |
| Depreciation & Amortization | $2.37M | $2.15M | -- | -- | $18K | $15K | $121K | $17K | $174K | $92K |
| Stock-Based Compensation | -- | -- | -- | -- | $392K | $55K | $347K | $6.59M | $1.83M | $0 |
| Change in Inventory | -- | -- | $1.50M | $6.11M | -$7.80M | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$12.79M | $1.18M | $1.35M | -$3.25M | -$8.63M | $10.06M | -$58.28M | -$1.73M | $87.72M | $8.19M |
| Capital Expenditure | -$1.6K | -$154K | -- | -- | -$4.9K | -- | -$200K | -$7.6K | -$456K | -$288K |
| **Free Cash Flow** | -$12.79M | $1.02M | -- | -- | -$8.63M | -- | -$58.48M | -$1.74M | $87.27M | $7.90M |
| Acquisitions, Net | -- | -$93.75M | -$56.25M | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$163.5M | -$105.9M | -$54.72M | $18.47M | -$19.96M | -$662 | $12.78M | -$68.11M | -$27.62M | -$288K |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -$2.67M | -$1.32M | -- | -- |
| Dividends Paid | -- | -- | -- | -- | -- | -- | -- | -$19.55M | -- | -- |
| **Financing Cash Flow** | $350K | $195.9M | $131.7M | -$27.51M | $34.78M | -$9.04M | -$1.55M | -$29K | $47.52M | $4.29M |
| **Net Change in Cash** | -$176.1M | $90.03M | $77.01M | -$12.73M | $6.80M | $4.20M | -$46.45M | -$75.25M | $113.4M | $11.41M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -0.1% | -1.9% | 5.1% | 9.6% | 10.1% | 100.0% | 100.0% | -100.2% | 100.0% | 100.0% |
| **Operating Margin** | -149.7% | -1125.4% | -357.8% | -108.2% | -54.3% | -241.7% | -695.7% | -194.6% | 70.7% | 43.3% |
| **Net Profit Margin** | -135.0% | -913.4% | -391.8% | -10.3% | -280.9% | -1984.5% | -1029.7% | 149.7% | 61.1% | 37.4% |
| Return on Equity (ROE) | -10.3% | -67.8% | -6.8% | -15.6% | -137.2% | -201.6% | -148.0% | 4.4% | 46.8% | 36.5% |
| Return on Assets (ROA) | -9.8% | -62.8% | -6.7% | -6.6% | -26.8% | -109.9% | -88.5% | 3.2% | 40.0% | 30.2% |
| Current Ratio | 21.77x | 14.20x | 39.52x | 1.76x | 1.24x | 2.09x | 4.21x | 3.68x | 6.84x | -- |
| Quick Ratio | 21.74x | 14.18x | 39.46x | 1.62x | 1.09x | 1.05x | 0.54x | 2.17x | 5.56x | -- |
| Debt to Equity | 0.00x | 0.00x | -- | -- | -- | -- | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | -6.4% | +512.1% | -81.7% | +119.7% | +241.9% | -74.6% | +87.1% | -96.6% | +368.0% | -- |
| Gross Profit Growth (YoY) | -- | -330.5% | -90.4% | +109.7% | -65.5% | -74.6% | -- | -103.5% | +368.0% | +92.7% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -109.5% | +665.4% | +139.4% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -1386.9% | -91.6% | +664.0% | +142.2% |
| EPS Growth (YoY) | -93.8% | +128.6% | -- | -- | -- | -- | -1427.3% | -92.5% | +630.0% | +150.0% |
| Operating Cash Flow Growth (YoY) | -1186.6% | -12.9% | -- | -- | -185.8% | -- | -- | -102.0% | +971.1% | +16.6% |
| Free Cash Flow Growth (YoY) | -1350.9% | -- | -- | -- | -- | -- | -- | -102.0% | +1004.4% | +14.4% |
| 5Y Revenue / Share Growth | -82.2% | -87.8% | -77.5% | -91.9% | -81.4% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -158.8% | -101.4% | -239.6% | -948.1% | -- | -- | -- | -- |
| 10Y Net Income / Share Growth | -110.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
